Novel small molecules and monoclonal antibodies for the treatment of vascular disease and to enhance wound healing, specifically diabetic macular edema and inflammatory bowel disease
Start Trial Get Full Profile
There’s no risk. Start your trial today to see profiles of Aerpio Therapeutics plus 4860 other startups.
